<SEC-DOCUMENT>0002069239-26-000005.txt : 20260604
<SEC-HEADER>0002069239-26-000005.hdr.sgml : 20260604
<ACCEPTANCE-DATETIME>20260604200006
ACCESSION NUMBER:		0002069239-26-000005
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20260602
FILED AS OF DATE:		20260604
DATE AS OF CHANGE:		20260604

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Doyle Janeen Noel
		CENTRAL INDEX KEY:			0002069239
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-40475
		FILM NUMBER:		261066570

	MAIL ADDRESS:	
		STREET 1:		10955 VISTA SORRENTO PARKWAY, SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Janux Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001817713
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		EIN:				822289112
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		10955 VISTA SORRENTO PARKWAY
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 751-4493

	MAIL ADDRESS:	
		STREET 1:		10955 VISTA SORRENTO PARKWAY
		STREET 2:		SUITE 200
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-06042026_080601.xml
</DOCUMENT>
</SUBMISSION>